4.7 Review

Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer

Journal

MOLECULAR ONCOLOGY
Volume 13, Issue 1, Pages 26-45

Publisher

WILEY
DOI: 10.1002/1878-0261.12409

Keywords

lncRNA; miRNA; MYC; ncRNA

Categories

Funding

  1. Lymph Co
  2. Dutch Cancer Society (KWF) [10478/2016-1]
  3. National Science Centre, Poland [2016/23/D/NZ1/01611]

Ask authors/readers for more resources

Myelocytomatosis viral oncogene homolog (MYC) plays an important role in the regulation of many cellular processes, and its expression is tightly regulated at the level of transcription, translation, protein stability, and activity. Despite this tight regulation, MYC is overexpressed in many cancers and contributes to multiple hallmarks of cancer. In recent years, it has become clear that noncoding RNAs add a crucial additional layer to the regulation of MYC and its downstream effects. So far, twenty-five microRNAs and eighteen long noncoding RNAs that regulate MYC have been identified. Thirty-three miRNAs and nineteen lncRNAs are downstream effectors of MYC that contribute to the broad oncogenic role of MYC, including its effects on diverse hallmarks of cancer. In this review, we give an overview of this extensive, multilayered noncoding RNA network that exists around MYC. Current data clearly show explicit roles of crosstalk between MYC and ncRNAs to allow tumorigenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available